Study of family genetic risk for joint implant infections
Part of Bones, joints & muscles, Genetic & congenital, Infections clinical trials.
This study looks at whether certain families have a higher genetic risk for infections around joint implants. It may help researchers understand who is more at risk and how to prevent these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You belong to a family where past information suggests a high risk of joint implant infections
- You may be asked about family medical history (your family pedigree)
- You can join even if you do not currently have the infection
- You can participate as an unaffected person
- Your relation must be within 3rd-degree (for example, parent, sibling, child; or cousin/uncle depending on how the study defines it)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have an infection around a hip, knee, or shoulder implant (prosthesis). It uses standard infection tests (like cultures and blood tests) to confirm the diagnosis and better understand this problem after surgery.
This study is testing a new, advanced lab test that can quickly identify exactly which bacteria are causing a joint implant infection. The goal is to help doctors choose the right antibiotics and improve treatment success.
This study looks at whether certain blood tests (called biomarkers) taken before surgery can help predict how well you do after a two-step joint replacement surgery to treat an infection. The goal is to improve care for people with joint infections.
This study looks for tiny markers in your blood and tissue that can tell whether a hip replacement is failing because of infection or another reason. By taking extra samples during your planned revision surgery, researchers hope to improve how infections are diagnosed in the future.
This trial uses advanced molecular methods to better diagnose infections in hip or knee replacement joints. The goal is to find infections more accurately so you can get the right treatment sooner.
This study looks for biomarkers (clues) in the joint fluid that can help tell whether an artificial joint is infected. It might help doctors diagnose infections faster and more accurately in the future.
Hear when a new Total Joint Arthroplasty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.